Menu

Nicole MAIRON

Boulogne-Billancourt

Electionseuropéennes 2024

RETROUVEZ GRATUITEMENTLe résultat des européennes à Paris.

En résumé

Mes compétences :
Clinical Development
Management
Médical

Entreprises

  • Roche - Safety Science Leader, Global, MabThera/Rituxan, Auto-Immune diseases

    Boulogne-Billancourt 2012 - maintenant

  • Merck-Serono - Geneva - Switzerland - Sr Medical Director Endocrinology Clinical Development and Medical Affairs

    2010 - 2012 European approval of a new liquid formulation for SAIZEN (growth hormone)

  • Wyeth Pharmaceuticals - Paris - France - Head of Women's Health and Bone Repair for Europe

    2008 - 2010 European approval for Bazedoxifene (Conbriza), treatment for postmenopausal osteoporosis

    Wyeth from 1998 to 2003 and 2008 to 2010

  • Hoffmann La Roche - Basel - Switzerland - Clinical Science Leader

    2003 - 2008 Approval worldwide of Boniva-Bonviva monthly tablets for Osteoporosis
    First in Man of a new chemical entity for chronic pain and overactive bladder
    Implementation of phase II with Ocrelizumab in RRMS

Formations

Pas de formation renseignée

Réseau

Annuaire des membres :